Loading clinical trials...
Loading clinical trials...
A study evaluating the drug levels of ipilimumab alone and in combination with nivolumab applied under the skin in various tumor types
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT07003542 · Glioblastoma, Brain Tumor
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT07060989 · Advanced Solid Tumors
NCT06813079 · Pancreatic Ductal Carcinoma, Advanced Cancer, and more
NCT05533697 · Advanced Solid Tumors
Local Institution - 0020
Hartford, Connecticut
Local Institution - 0013
Fort Wayne, Indiana
Istituto Nazionale Tumori IRCCS Fondazione Pascale-s.c. melanoma, immunoterapia oncologica e terapie
Naples
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions